Work

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(08)70035-4

Authors: Wasaburo Koizumi, Hiroyuki Narahara, Takuo Hara, Akinori Takagane, Toshikazu Akiya, Masakazu Takagi, Kosei Miyashita, Takashi Nishizaki, Osamu Kobayashi, Wataru Takiyama, Yasushi Toh, Takashi Nagaie, Seiichi Takagi, Yoshitaka Yamamura, Kimihiko Yanaoka, Hiroyuki Orita, Masahiro Takeuchi

Institutions: Kitasato University, Osaka International Cancer Institute, Kouseiren Takaoka Hospital, Iwate Medical University, Gunma Prefectural Cancer Center, Shizuoka General Hospital, Nagasaki Medical Center, National Hospital Organization, Matsuyama Red Cross Hospital, Kanagawa Cancer Center, Hiroshima City Asa Citizens Hospital, National Hospital Organization Kyushu Cancer Center, Aso Iizuka Hospital, Aichi Cancer Center, Aichi Cancer Center Hospital, Wakayama Medical University, Saga-Ken Medical Centre Koseikan

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Taiho Pharmaceutical

OpenAlex ID: W2171075804

FWCI: 63.34

Cites: 29

Cited by: 1,868

Related to: 10